Discrimination Associated With Higher Risk of Depression
A group of researchers explored whether individuals who experienced ongoing discrimination had a higher risk for depression.
More Topics
Novavax Submits EUA Request for COVID-19 Vaccine Booster
The submission is supported by data from the phase 3 PREVENT-19 trial and the phase 2 COV-BOOST trial.
Antibiotics and Older-Onset IBD: Increased Risk in Adults Older Than 60
Adam S. Faye, MD, discusses his team’s research on how antibiotics increase the risk for inflammatory bowel disease among older adults and what clinicians should keep in mind.
Noradrenergic Drugs Improve Cognition, Apathy in Alzheimer Disease
Researchers sought to evaluate the efficacy of noradrenergic drugs in the improvement of neuropsychiatric and cognitive symptoms in individuals with AD.
Mental Health Professionals Together With Paramedic First Responders, Not Police, Decrease Nonviolent Crime Rates
Researchers looked at whether a program with health-focused first responders reduced less serious crimes.
Deoxycytidine Kinase Inhibitor Designated Orphan Drug for Optic Neuritis
Optic neuritis is a rare autoimmune disease characterized by the inflammation of the optic nerve.
Rheumatoid Arthritis Likely Plays Causal Role in Inflammatory Bowel Disease
Researchers assessed whether rheumatoid arthritis is causally related to inflammatory bowel disease and vice versa.
FDA Authorizes Intradermal Use of Jynneos to Increase Supply During Monkeypox Outbreak
Under the EUA, Jynneos can be administered either intradermally for individuals aged ≥18 years or subcutaneously for individuals aged <18 years.
Ensifentrine Improves Lung Function, Cuts COPD Exacerbations in Late Stage Trial
Ensifentrine (RPL554) is a first-in-class, dual phosphodiesterase (PDE) 3 and 4 inhibitor with combined bronchodilator and anti-inflammatory actions.
Xanomeline-Trospium Improves Schizophrenia Symptoms in Phase 3 Trial
The phase 3 EMERGENT-2 trial included 252 patients with schizophrenia who were experiencing symptoms of psychosis.
Mediterranean Diet Remains Effective Treatment for Nonalcoholic Fatty Liver Disease
Researchers analyzed the effects of the Mediterranean diet and calorie restriction interventions to determine the most effective dietary management for NAFLD.
Can Consuming Micronutrients Affect Ulcerative Colitis Risk?
Researchers examined the association between micronutrient intake and the risk for ulcerative colitis.
Delta vs Omicron: Which Variant Has a Higher Risk for Long COVID?
Using a symptom tracker app, researchers assessed the risk for long COVID among patients infected with the Delta or the Omicron variant between 2 time periods.
Patisiran Promising for Transthyretin-Mediated Amyloidosis With Cardiomyopathy
The APOLLO-B study included patients 18 years of age and older with ATTR amyloidosis (hereditary or wild-type) with cardiomyopathy.
FDA to Review Resubmitted Application for Severe Burn Therapy NexoBrid
NexoBrid is a topically administered, bromelain-based biological product containing a sterile mixture of proteolytic enzymes.
Rebinyn Approval for Hemophilia B Expanded to Include Routine Prophylaxis
Rebinyn is a recombinant DNA-derived coagulation Factor IX concentrate with an extended half-life.
FDA Approves Oral Testosterone Replacement Therapy Kyzatrex
The FDA has approved Kyzatrex (testosterone undecanoate) for the treatment of primary and secondary hypogonadism in adult males.
Guideline for Preventing Weight Gain in Women at Midlife
Panel recommends counseling all women aged 40 to 60 years on healthy eating and physical activity to maintain weight or prevent weight gain.
Report: Ransomware Attacks Rise Sharply
Ransomware attacks now account for 25% of all data breaches, according to Verizon’s 2022 Data Breach Investigation Report.
Identifying Risk Factors for Alzheimer Disease: Are They Modifiable?
Ines Moreno-Gonzalez, PhD, an adjunct associate professor of neurology, explains healthy aging can help reduce lifestyle risk factors for Alzheimer disease.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Ethics
Loading... 
Loading...